Key facts
- This page summarizes Luisa Puche's Form 4 filing for RENOVARO BIOSCIENCES INC. (RENB).
- 8 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 16 Feb 2024, 09:13.
Luisa Puche - 13 Feb 2024 Form 4 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RENB
- Reported as of
- 13 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Feb 2024, 09:13:55 UTC
- Prior SEC filing
- 27 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Luisa Puche
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Luisa Puche filed Form 4 for RENOVARO BIOSCIENCES INC. (RENB) on 16 Feb 2024.
Change
- Previous filing in this sequence was filed on 27 Oct 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RENB
transaction
Derivative
Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -60,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 13 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,000
- Exercise price
- $6.15
- Footnotes
- F1, F2
RENB
transaction
Derivative
Option to Purchase Common Stock
Award
- Transaction value
- Shares
- +60,000
- Change %
- Price
- Shares after
- 60,000
- Date
- 13 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,000
- Exercise price
- $1.92
- Footnotes
- F2
RENB
transaction
Derivative
Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -60,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 13 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,000
- Exercise price
- $8.58
- Footnotes
- F2, F3
RENB
transaction
Derivative
Option to Purchase Common Stock
Award
- Transaction value
- Shares
- +60,000
- Change %
- Price
- Shares after
- 60,000
- Date
- 13 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,000
- Exercise price
- $1.92
- Footnotes
- F2
RENB
transaction
Derivative
Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -75,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 13 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $2.38
- Footnotes
- F2, F4
RENB
transaction
Derivative
Option to Purchase Common Stock
Award
- Transaction value
- Shares
- +75,000
- Change %
- Price
- Shares after
- 75,000
- Date
- 13 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $1.92
- Footnotes
- F2
RENB
transaction
Derivative
Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -80,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 13 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $2.15
- Footnotes
- F2, F5
RENB
transaction
Derivative
Option to Purchase Common Stock
Award
- Transaction value
- Shares
- +80,000
- Change %
- Price
- Shares after
- 80,000
- Date
- 13 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $1.92
- Footnotes
- F2, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The option vested in three equal installments on January 7, 2019, January 7, 2020 and January 7, 2021.
Footnote F2
The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.
Footnote F3
The option vested in three equal installments on October 26, 2021, October 26, 2022 and October 26, 2023.
Footnote F4
The option vested on January 22, 2023.
Footnote F5
One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025.